CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $21.93M, above the global median of $18.73M
- FinancialsAltman Z-Score 10.48: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.97%Above 5Y avg (1.26%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
52.6%Sustainable
Payback Period
53.0 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.30BCNY791.35M · vs all stocks (USD)
Trailing P/E
20.28xRevenue (TTM)
1.01BCNY150.85M · vs all stocks (USD)
Profit Margin
25.58%Beta
0.1690xvs all stocks
52-Week Change
-17.02%vs all stocks
Market Capitalization
5.30BCNY791.35M · vs all stocks (USD)
Enterprise Value
4.07BCNY607.80M · vs all stocks (USD)
Trailing P/E
20.28xForward P/E
19.50xPrice to Sales (TTM)
5.25xPrice to Book (MRQ)
1.24xEnterprise to Revenue
4.03xEnterprise to EBITDA
14.82xGross Margin
79.14%Profit Margin
25.58%Operating Margin
19.62%Return on Assets (TTM)
3.26%Return on Equity (TTM)
6.04%Revenue (TTM)
1.01BCNY150.85M · vs all stocks (USD)
Revenue per Share (TTM)
0.9670CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-11.90%Gross Profit (TTM)
810.65MCNY120.97M · vs all stocks (USD)
EBITDA (TTM)
270.23MCNY40.32M · vs all stocks (USD)
Net Income (TTM)
258.56MCNY38.58M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-1.60%Operating Cash Flow (TTM)
179.72MCNY26.82M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
146.95MCNY21.93M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
1.97%vs all stocks
5-Year Average Dividend Yield
1.26%vs all stocks
Payout Ratio
52.59%Minority Interest (Equity)
388.25KCNYFY2025 · Dec 31, 2025Revenue
1.15BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
222.04MCNYFY2025 · Dec 31, 2025Gross Profit
930.62MCNYFY2025 · Dec 31, 2025Operating Income
272.44MCNY40.65M · vs all stocks (USD)
Pre-tax Income
322.05MCNYFY2025 · Dec 31, 2025Income Tax Expense
44.05MCNYFY2025 · Dec 31, 2025Net Income
278.00MCNYFY2025 · Dec 31, 2025EBIT
322.15MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
365.91MCNYFY2025 · Dec 31, 2025Research & Development
88.27MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
446.19MCNYFY2025 · Dec 31, 2025Other Operating Expenses
17.61MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
41.15MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
98.73KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2663CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2663CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.05BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.05BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
278.00MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
580.48KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
292.17MCNYFY2025 · Dec 31, 2025Free Cash Flow
265.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
969.39MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
278.00MCNYFY2025 · Dec 31, 2025Other Non-cash Items
763.47KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
23.40MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-10.00MCNYFY2025 · Dec 31, 2025Capital Expenditures
-26.53MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.15BCNYFY2025 · Dec 31, 2025Sale of Investments
3.49BCNYFY2025 · Dec 31, 2025Other Investing Activity
-15.26MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
291.54MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-235.93KCNYFY2025 · Dec 31, 2025Common Dividends Paid
-136.03MCNYFY2025 · Dec 31, 2025Other Financing Charges
1.32MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-134.95MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.05BSharesUpdated Sep 20, 2026Float Shares
636.02MSharesUpdated Sep 20, 2026% Held by Insiders
40.53%vs all stocks
% Held by Institutions
1.42%vs all stocks
Total Cash (MRQ)
1.24BCNY184.38M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.18CNYUpdated Sep 20, 2026Total Debt (MRQ)
5.41MCNY806.59K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0013xCurrent Ratio (MRQ)
13.36xBook Value per Share (MRQ)
4.10CNYUpdated Sep 20, 2026Total Assets
4.78BCNY713.03M · vs all stocks (USD)
Total Current Assets
2.24BCNYFY2025 · Dec 31, 2025Total Liabilities
359.64MCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.54BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
192.73MCNYFY2025 · Dec 31, 2025Total Current Liabilities
166.91MCNYFY2025 · Dec 31, 2025Cash
944.74MCNYFY2025 · Dec 31, 2025Cash Equivalents
35.97MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
980.71MCNYFY2025 · Dec 31, 2025Other Short-term Investments
58.53MCNYFY2025 · Dec 31, 2025Accounts Receivable
292.08MCNYFY2025 · Dec 31, 2025Inventory
200.41MCNYFY2025 · Dec 31, 2025Accounts Payable
93.61MCNYFY2025 · Dec 31, 2025Short-term Debt
4.08MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.34MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.05BCNYFY2025 · Dec 31, 2025Retained Earnings
2.22BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.42BCNY659.36M · vs all stocks (USD)
52-Week Low
4.02CNYUpdated Sep 20, 202652-Week High
6.77CNYUpdated Sep 20, 202652-Week Change
-17.02%vs all stocks
Beta
0.1690xvs all stocks
50-Day MA
5.53CNYUpdated Sep 20, 2026200-Day MA
5.73CNYUpdated Sep 20, 2026Avg 10-Day Volume
16.11MSharesUpdated Sep 20, 2026Avg 30-Day Volume
43.97MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.2500CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.48: safe zoneNotable
Altman Z-Score: 10.48
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $21.93M, above the global median of $18.73MNotable
Levered free cash flow (USD): 21,927,769.174Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Oxford Biomedica plc
Tier 1ProductionApproval-Gated PipelineFlowRule
Shanxi Zhendong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chengda Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Jiudian Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
HK inno.N Corporation
Tier 1ProductionApproval-Gated PipelineRule
Immix Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Varex Imaging Corporation
Tier 1ProductionApproval-Gated PipelineRule
4D Molecular Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jacobio Pharmaceuticals Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Luoxin Pharmaceuticals Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Eastech Holding Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
ASPEED Technology Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Integral Corp.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities